Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
Objective To generate a score which clinically identifies surface-directed autoantibodies in adults with new-onset focal epilepsy, and evaluate the value of immunotherapy in this clinical setting.
Methods Prospective clinical and autoantibody evaluations in a cohort of 219 consecutive patients with new-onset focal epilepsy.
Results 10.5% (23/219) of people with new-onset focal epilepsy had detectable serum autoantibodies to...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
(Version of record, 540.4KB)
- Publisher copy:
- BMJ Publishing Group Publisher's website
- Journal of Neurology, Neurosurgery and Psychiatry Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Deposit date:
- Copyright holder:
- McGinty R et al.
- Copyright date:
- Rights statement:
- © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made.
- CC Attribution (CC BY)
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record